Morphine tolerance and transcription factor expression in mouse spinal cord tissue

Neuroscience Letters

Volumn 272, Issue 2, 1999, Pages 79-82

  Li, Xiangqi ^a   Clark, J David ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Fos B; C Fos; CREB; Fos B; Morphine; Spinal cord; Tolerance

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IMMUNOHISTOLOGY; LONG TERM EXPOSURE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPINAL CORD DORSAL HORN; SUBCUTANEOUS DRUG ADMINISTRATION; WESTERN BLOTTING;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG TOLERANCE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MORPHINE; PROTO-ONCOGENE PROTEINS C-FOS; SPINAL CORD;

EID: 0032876614     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00559-5     Document Type: Article

References (20)

1. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain. 68:1996;229-237.
2. Chen J., Kelz M.B., Hope B.T., Nakabeppu Y., Nestler E.J. Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J. Neurosci. 17:1997;4933-4941.
3. Clark J.D., Tempel B.L. Hyperalgesia in mice lacking the Kv1.1 potassium channel gene. Neurosci. Lett. 251:1998;121-124.
4. Curran E.J., Akil H., Watson S.J. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem. Res. 21:1996;1425-1435.
5. Gonzalez G.A., Montminy M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59:1989;675-680.
6. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58:1992;1168-1171.
7. Lane-Ladd S.B., Pineda J., Boundy V.A., Pfeuffer T., Krupinski J., Aghajanian G.K., Nestler E.J. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17:1997;7890-7901.
8. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA. 91:1994;8537-8541.
9. Mao J., Price D.D., Lu J., Mayer D.J. Antinociceptive tolerance to the muopioid agonist DAMGO is dose-dependently reduced by MK-801 in rats (In Process Citation). Neurosci. Lett. 250:1998;193-196.
10. Matus-Leibovitch N., Ezra-Macabee V., Saya D., Attali B., Avidor-Reiss T., Barg J., Vogel Z. Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment. Brain Res. Mol. Brain Res. 34:1995;221-230.
11. + channels in rat spinal cord. Brain Res. Mol. Brain Res. 40:1996;261-270.
12. Nestler E.J. Molecular mechanisms of opiate and cocaine addiction. Curr. Opin. Neurobiol. 7:1997;713-719.
13. Nye H.E., Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49:1996;636-645.
14. Pataki I., Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. Eur. J. Pharmacol. 357:1998;157-162.
15. Quaicoe S., McLaughlin R., Hassenbusch S. Intrathecal opiate therapy and implantable devices. Payne R.P.R., Stratton Hill C. Assessment and Treatment of Cancer Pain. 12:1998;223-256 IASP Press, Houston, TX.
16. Rohde D.S., Basbaum A.I. Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat. J. Neurosci. 18:1998;4393-4402.
17. Vinik H.R., Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth. Analg. 86:1998;1307-1311.
18. 3H]glyburide binding to mouse brain and spinal cord. Drug Alcohol Depend. 45:1997;47-53.
19. Widnell K.L., Self D.W., Lane S.B., Russell D.S., Vaidya V.A., Miserendino M.J., Rubin C.S., Duman R.S., Nestler E.J. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 276:1996;306-315.
20. Zhao G.M., Bhargava H.N. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice. Peptides. 17:1996;619-623.